CMS Reimbursement-Ready†
Diabetes
Testing
Centers™
& Chronic Care Programs®
with Payer-Approved
#1 Neuropathy Pain Program (18 Visits, CMS-Reimbursable)
CMS Reimbursement-Ready†
Diabetes
Testing
Centers™
& Chronic Care Programs®
with Payer-Approved
We help clinics test and treat chronic conditions using reimbursement-ready technologies before referrals are needed.
Before...
Alzheimer’s dims minds,
Amputations end walks,
Blindness shrouds sunsets,
Heart attacks shatter bonds,
Prevent tomorrow's heartaches today.
find what others miss
At Diabetes Testing Centers™ (DTC), we were founded by former family practice owners who saw the consequences of delayed detection, missed reimbursements, and preventable complications in everyday care. With a provider network of more than 20,000 clinics nationwide, our mission is to close these gaps for patients with diabetes and other chronic conditions from head-to-toe through innovative, non-invasive, point-of-care technology. We provide turnkey programs that are CMS reimbursement-ready, can improve care, and reduce costs—all while aligning with an organization’s unique care philosophy.
Our Chronic Care Programs® are designed for comprehensive assessments, longitudinal care, structured visits (18+) to monitor progress and adjust treatment plans as needed. These programs are designed as ongoing preventive pathways, with multiple reimbursable visits that allow providers to track progress, adjust care, and strengthen patient outcomes over time. Epidemiological data and longitudinal clinical evidence place neuropathy firmly at the front of the diabetes complication cascade, making it the most common and earliest complication of diabetes, affecting up to 50% of patients. Neuropathy signals systemic microvascular damage that precedes other conditions such as cardiovascular disease, cognitive decline, ulcers, amputations and more. Addressing it early not only secures vital clinical data and reimbursable revenue but also interrupts the cascade of complications that often follow.
Structured Pathways to Better Outcomes
Objective Assessments: Evidence-based testing used to create a personalized treatment plan.
Structured Visits: A defined course of 18–36 visits to monitor progress and adjust care.
Long-Term Therapeutic Care: Designed for sustained, ongoing support over time.
This dual approach lets you proactively identify risks tied to diabetic neuropathy and other chronic conditions while strengthening in-house care. By using our solutions, we can help more families keep their time together longer.
Preventable Conditions Shouldn't Be Fatal
Take Your Pick
CMS Reimbursement-Ready
CMS Reimbursement-Ready
Turnkey: Assessment & Therapies
Early Detection with Our Alzheimer's & Dementia Program Gives Families More Time and Memories to Share.
Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable.
Each test is grounded in medical necessity for early detection, takes an average of three minutes or less, and addresses the serious complications that diabetic patients are most vulnerable to developing. This includes peripheral neuropathy testing, retinopathy screening, cognitive assessments, cardiovascular risk evaluation, and PAD screening.
What sets DTC apart is our ability to integrate these non-invasive, in-office tools into your clinic seamlessly. Our exclusive turnkey Chronic Care Programs® are designed for primary care and multispecialty settings. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver up to 25 reimbursable programs—without requiring new staff, new construction, or disruption to your workflow.
These Programs are a Pathway to:
Protect patients by detecting disease earlier, before costly and irreversible damage occurs
Keep care and revenue in-house instead of referring patients away
Simplify adoption by relying on DTC for backend support, billing pathways, and workflow integration
Align your practice with today’s value-based care priorities, improving quality scores, STAR ratings, and patient trust
Strategy for Engagement:
Emphasize the Gap: Most clinics are already checking glucose, but missing the greater opportunity to uncover the conditions that actually lead to blindness, amputations, dementia, and cardiovascular events.
Lower the Barrier: With tests averaging three minutes, DTC makes it easy to adopt without adding strain to your staff. Highlight financial upside: Each program is CMS-approved, fully reimbursable, and positioned to open new revenue streams in as little as 30 days.
Build Trust: Position DTC’s turnkey programs as clinically validated, medically necessary, and nationally recognized—giving providers confidence in their adoption.
Provide Proof: Share success stories and case studies showing how early detection has changed both patient outcomes and practice economics.
By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.
60% of People are Living with One Chronic Disease
Primary Care Providers (PCP) check patients blood glucose but why stop there? With in-clinic neuropathy, cognitive, or vascular testing, you can diagnose earlier, act sooner, and keep care under your roof instead of waiting on outside referrals. This means you’re not just monitoring—you’re diagnosing, acting sooner, and keeping patients under your care with clinically valuable results that directly improve outcomes.
Getting Started Is Simple:
Think about the top three patient referrals your clinic makes, like labs, neurology, podiatry, endocrinology, cardiology, physical therapy, or others. This helps you determine which patients have unmet needs that your clinic may fulfill.
Review our Chronic Care Programs® and pick one that aligns with the referrals you make. For example, if you send a lot of patients to neurology, choose our neuropathy testing program. If you refer to cardiology, consider our cardiovascular risk evaluation, etc.
Select a program with a zero-down option to begin testing these patients immediately in your clinic, without any upfront investment and get a financial pro forma from us based on your location and payor reimbursements. This allows you to start providing and billing for these services, regularly in 30 days or less.
your next referral could be A missed diagnosis
Neuropathy is the gateway to complications and our Diabetic Neuropathy Device™ (DND) tests small and large nerve fibers.
Neuropathy is the leading gateway to diabetes-related complications, signaling the earliest nerve damage from high blood sugar that often appears years before other conditions are diagnosed. If left unchecked, neuropathy can trigger a cascade of serious outcomes, including cognitive decline, depression, balance issues, cardiovascular disease, and more.
At Diabetes Testing Centers™ (DTC), our Chronic Care Programs® give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams.
Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike.
Our turnkey programs make it possible to intervene earlier with rapid, non-invasive, point-of-care tools such as neuropathy testing, PAD screening, cognitive assessments, and cardiovascular risk evaluations. Each fits seamlessly into your workflow, enabling your team to detect risks, initiate treatment plans, and manage progression both in-clinic and remotely. The result is better outcomes for patients, stronger trust in your care, and new reimbursable revenue streams that support practice growth.
Strategy for Engagement:
Position for Impact: We highlight the fact that most providers already check blood glucose but miss the chance to screen for the complications that actually drive hospitalizations and long-term costs.
Reduce Complexity: With DTC, you don’t need new staff or complicated systems. We provide the workflow, billing guidance, and backend support so you can launch in 30 days or less.
Clinical and Financial Win: Early detection preserves vision, kidney function, mobility, and quality of life while helping your practice capture reimbursements from services you’re currently referring away.
Showcase Success: Shared case studies, peer-to-peer webinars, and onsite demos give providers tangible proof of how easily these programs fit into real-world practice.
Keep Your Workflow, Change Your Tools!
National Guideline Recommendations
National guidelines recommend that primary care physicians, endocrinologists, podiatrists, and neuropathy specialists screen all diabetic patients for neuropathy at least once a year. Neuropathy is one of the earliest and most common complications of diabetes, and its detection has important clinical implications.
Small fiber neuropathy is often the first sign of metabolic dysfunction or poorly controlled diabetes, serving as an early warning that systemic complications may be developing.
Large fiber neuropathy, on the other hand, is closely tied to loss of protective sensation—leading to falls, infections, wounds, and ultimately amputations and inspected at every visit once identified.
When neuropathy is detected, it not only signals nerve damage but also indicates an elevated risk of other serious diabetes-related complications such as cardiovascular disease, renal decline, and vision loss, all of which share the same underlying metabolic origin. When you can Screen, Test and Treat in-house and remotely, you not only keep patients under your care, you break the chain reaction at its source. That’s what makes our Chronic Care Programs® more than just assessments, they are the bridge between routine care and long-term health.
Neuropathy is a serious condition that, if not accurately diagnosed and treated promptly, can lead to devastating outcomes, such as amputations of the toes, feet, or legs. The failure to adopt advanced diagnostic tools and procedures has resulted in medical institutions and physicians being held liable for malpractice. A landmark case, Washington v. Washington Hospital (1990)., set legal precedent in the U.S. regarding this issue.
Get Reimbursed for Foot Exams
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.